Biological Causes of Schizophrenia

Genetic studies show that family history significantly increases schizophrenia risk. Identical twins are three times more likely to develop the condition than fraternal twins, demonstrating strong hereditary influence. Scientists identified a C4 gene variant associated with the immune system and synaptic pruning, linking genetic factors to brain development abnormalities during adolescence and early adulthood.

Brain imaging reveals multiple structural differences in schizophrenia: a smaller frontal cortex, enlarged ventricles indicating brain tissue loss, larger sulci, and smaller temporal lobes. Individuals also show decreased activity in the amygdala and hippocampus, along with reduced symmetry between brain hemispheres. These abnormalities disrupt critical cognitive functions like thinking, planning, and organizing thoughts.

Synaptic pruning removes excess neural connections in brain regions responsible for thinking and planning. In schizophrenia, this pruning becomes excessively pronounced during adolescence and early adulthood, eliminating critical neural connections needed for proper brain function. This overactive pruning, influenced by genetic and environmental factors, impairs brain communication and contributes to symptom onset.

Abnormal dopamine receptors disrupt dopamine transmission, a hallmark of schizophrenia. These receptor abnormalities affect attention, memory, and motivation while linking dopamine pathways to symptoms like paranoia. Antipsychotic medications block dopamine receptors to reduce symptoms, though dopamine dysregulation alone does not fully explain schizophrenia, as other neurotransmitters like glutamate and serotonin also contribute.

Yes, environmental factors can trigger schizophrenia in genetically predisposed individuals. Prenatal infections may predispose the brain to develop schizophrenia during puberty and young adulthood. Additionally, adolescent marijuana use can trigger the condition in those with genetic vulnerability. These environmental stressors interact with biological predisposition to influence disorder onset and progression.

While dopamine dysregulation is central to schizophrenia, multiple neurotransmitter systems contribute to the disorder. Norepinephrine, glutamate, and serotonin imbalances also play important roles in schizophrenia pathophysiology. This complex neurotransmitter dysregulation explains why dopamine alone cannot account for all symptoms and why treatment often targets multiple neurochemical systems.

Schizophrenia results from a complex interplay of genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. Genetic factors increase vulnerability, while abnormal synaptic pruning and brain tissue loss during adolescence create structural changes. Neurotransmitter imbalances then disrupt neural communication, producing positive symptoms of schizophrenia hallucinations and delusions alongside cognitive and negative symptoms.